Announcements Trials

Browse Landscape

Phase

Phase NA 2 Phase 2 2 Phase EARLY_PHASE1 1

Status

Recruiting 2 Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1 Inflammation 1

Interventions

Magnetic Resonance Spectroscopy 23 Metformin 14 pembrolizumab 12 Radiotherapy 12 Biopsy 11 Nivolumab 9 Fluorouracil 9 Cyclophosphamide 9 Temozolomide 7 Radiation 7 Bevacizumab 7 gallium 68 PSMA-11 6 Sirolimus 6 Rituximab 6 Letrozole 6 Etoposide 6 Cisplatin 6 Aspirin 6 olaparib 5 Surveys and Questionnaires 5 Radiosurgery 5 Oxaliplatin 5 Irinotecan 5 Indocyanine Green 5 Granulocyte Colony-Stimulating Factor 5 Fluorodeoxyglucose F18 5 Dexamethasone 5 aldesleukin 4 Surgical Procedures, Operative 4 Proflavine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Completed × Spironolactone × Clear all

NCT02689843 2019-11-12

AntiPCO

Shiraz University of Medical Sciences

Phase EARLY_PHASE1 Completed

Inflammation, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡